市場調查報告書

全球豬疫苗市場:各產品,各終端用戶,各用途,各地區 - 成長,趨勢,預測

Porcine Vaccine Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 704727
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球豬疫苗市場:各產品,各終端用戶,各用途,各地區 - 成長,趨勢,預測 Porcine Vaccine Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

本報告提供全球豬疫苗市場相關調查,彙整市場現狀與今後的成長預測,各市場區隔趨勢,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要

  • 目前市場方案
  • 波特五力分析

第6章 促進要素,阻礙要素,機會,課題分析

  • 推動市場的要素
  • 阻礙市場的要素
  • 機會
  • 課題

第7章 市場區隔

  • 對象各疾病
    • 腹瀉
    • 禽流感
    • 關節炎
    • 博德氏桿菌鼻炎
    • 豬繁殖·呼吸病毒
    • 豬環狀病毒相關疾病
    • 其他
  • 各技術
    • 不活化疫苗
    • 活病毒疫苗
    • 類毒素疫苗
    • 重組疫苗
    • 共軛疫苗
    • DNA疫苗
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第8章 競爭環境

  • 合併·收購分析
  • 協定,聯合,聯盟
  • 新產品上市

第9章 主要加入企業

  • Bayer AG.
  • IDT Biologika GmbH
  • HIPRA
  • Ceva
  • Elanco
  • Arko Laboratories, LTD.
  • Intervet Inc.
  • Merial
  • Vetoquinol
  • Zoetis Services LLC.

第10章 市場未來

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 62881

The recent years have witnessed a significant increase in the demand for pork and gelatin, an increase in the prevalence of swine diseases, and growth in R&D expenditure for innovation of vaccines. According to the world meat consumption statistics provided by the US Department of Agriculture - Foreign Agricultural Service (USDA - FAS), 40.4% of the total meat consumption, across the globe, in 2017 is accounted for by pork alone. The report also states that per capita pork consumption (lb, carcass weight) has observed significant growth, across many regions, as shown in the graph.

This increase in pork consumption is expected to give rise to a growing need of keeping the swine population free from every possible disease that could affect swine and pose a threat to the human population, owing to the rise in prevalence of several zoonotic diseases. As a result of this, the requirement for a variety of swine vaccines, targeting various porcine diseases, is expected to grow.

Key Market Trends

Porcine Circovirus Associated Disease is Expected to Witness a Healthy Growth

PCV (Porcine Circovirus) is the smallest non-enveloped, single-stranded DNA virus, which replicates autonomously in eukaryotic cells, using the host polymerase for genome amplification. Generally, the price of vaccines targeting porcine circovirus associated disease (PCVAD) can range from USD 50 to around USD 500. Commercially available PCVAD vaccines can be of many types, mainly based upon the dosage, packaging size, age of the pig it is used on, and virus type. Some of the major brands manufacturing and selling porcine vaccines for PCVAD, globally, are Boehringer Ingelheim, Merck, and Zoetis, among others. The first FLEX Family swine vaccine for PCV2 protection in a single injection was Ingelvac CircoFLEX, by Boehringer Ingelheim. Hence, it is one of the revolutionary PCV2 vaccines in the market.

United States Holds a Significant Market Share

Increasing pork consumption, the growing prevalence of various swine diseases, and rising per capita animal healthcare expenditure are the factors due to which the United States is expected to retain its large market share.

Europe is the second-largest market for Porcine Vaccine is expected to follow North America, while Asia-Pacific is expected to demonstrate highest growth rate owing to factors such as increasing demand for animal-based food products, especially in South-East Asia, rise in awareness about porcine health, and recent advancements in the field of biotechnology. Hence, the aforementioned factors are expected to fuel the growth of the Porcine Vaccine Market in the Asia Pacific.

Competitive Landscape

The porcine vaccines market is fairly competitive and consists of several major players. Most of these major players enjoy a global presence and are facing intense competition in emerging economies. The emerging countries are becoming hotspots for significant competition, due to a rapidly expanding market size, fueled by rising concerns over food safety and the increasing adoption of companion as well as farm animals.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growth in Demand for Pork and Gelatin
    • 4.2.2 Rise in Prevalence of Swine Diseases
    • 4.2.3 Increase in R&D Expenditure for Innovation of Vaccines
  • 4.3 Market Restraints
    • 4.3.1 High Expenses of Maintaining and Handling Storage Conditions
    • 4.3.2 Chance of Reverse Reaction from Vaccines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Target Disease
    • 5.1.1 Diarrhea
    • 5.1.2 Swine Influenza
    • 5.1.3 Arthritis
    • 5.1.4 Bordetella Rhinitis
    • 5.1.5 Porcine Reproductive and Respiratory Syndrome (PRRS)
    • 5.1.6 Porcine Circovirus Associated Disease (PCVAD)
    • 5.1.7 Other Target Diseases
  • 5.2 By Technology
    • 5.2.1 Inactivated Vaccines
    • 5.2.2 Live Attenuated Vaccines
    • 5.2.3 Toxoid Vaccines
    • 5.2.4 Recombinant Vaccines
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 COMPANY PROFILES
    • 6.1.1 Bayer AG
    • 6.1.2 IDT Biologika GmbH
    • 6.1.3 HIPRA
    • 6.1.4 Ceva Sante Animale
    • 6.1.5 Elanco
    • 6.1.6 Arko Laboratories Ltd
    • 6.1.7 Intervet Inc.
    • 6.1.8 Merial
    • 6.1.9 Vetoquinol
    • 6.1.10 Zoetis Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top